these processes determines whether viral infection is asymptomatic or progresses to produce 44 disease. While virus-host interactions are becoming increasingly well defined using cell-culture 45 models, mechanisms that contribute to viral pathogenesis at the organismal level are less well 46
understood. 47
Mammalian orthoreoviruses (reoviruses) have been used as models for studies of viral 48 pathogenesis. Reoviruses are enteric, nonenveloped viruses with a double-stranded (ds) RNA 49 genome (29). Peroral (PO) inoculation of newborn mice with reovirus leads to a disseminated 50 infection that causes damage to the central nervous system (CNS), heart, and liver (40). Strain-51 specific differences in reovirus tropism and virulence are linked to both viral and host factors. 52 Viral factors include receptor utilization (1, 3, 42 ) and sensitivity to type 1 interferons (IFNs) 53 (32), while host factors include components of innate and adaptive immunity (38, 39). Protection 54 against reovirus infection is mediated by both cell-mediated and humoral immune mechanisms. 55
Depletion of either CD4 + or CD8 + T cells abrogates or severely inhibits cell-mediated immune 56 protection against reovirus infection (30), whereas exogenously administered anti-reovirus 57 antibodies limit reovirus spread to the CNS (36). These adaptive immune mechanisms are for the 58 most part serotype-independent and display differences in efficacy depending on the tropism of 59 the infecting strain (39). 60
on August 30, 2017 by guest http://jvi.asm.org/ Downloaded from sterile 1 ml syringe, and the contents were transferred to a 15-ml conical tube on ice. The total 183 volume was adjusted to 15 ml, and splenocytes were incubated on ice for 5 min to allow debris 184 to settle. Debris was removed using a sterile transfer pipette, and cells were washed once with 185 RPMI 1640. 186
Intracellular cytokine staining. One day prior to assay, 5 x 10 6 C57SV fibroblasts were 187 either mock-infected or infected with reovirus T1L at an MOI of 500 PFU/cell and incubated at 188 Eppendorf tubes and incubated at 4°C overnight to allow blood to clot. Clotted blood was 202 centrifuged at 10,000 x g for 5 min, and the serum was transferred to fresh tubes and stored at -203 80°C. Either CsCl-purified reovirus T1L (10 10 particles) or an equivalent volume of mock-204 infected CsCl-purified lysate was adsorbed to wells of a 96-well EIA/RIA plate (Costar) in 50 µl 205 of 50 mM carbonate/bicarbonate buffer (pH 9.6) and incubated at 4°C overnight. Wells were 206 washed once with ELISA wash buffer (PBS containing 0.05% Tween-20) and incubated in 0.2 207 ml of ELISA blocking buffer (PBS containing 0.05% Tween-20 and 5% nonfat milk) at room 208 temperature for 3 h. The plates were washed twice with wash buffer and incubated with 4-fold 209 serial dilutions of serum in blocking buffer at 4°C overnight. The plates were washed three times 210 with wash buffer and incubated with a 1:1000 dilution of secondary antibody (HRP-conjugated 211 anti-mouse IgG, GE Healthcare) in 0.1 ml of ELISA blocking buffer at room temperature for 1 h. 212
Wells were washed four times with wash buffer and incubated with 0.1 ml of TMB substrate 213 (One-Step Ultra TMB-ELISA, Pierce) for 15 min. The reaction was stopped by adding 50 µl of 2 214 M sulfuric acid to each well, and the A 450 was determined using a SPECTRAmax PLUS384 215 RESULTS 217 218 IRF-3 is required for the induction of type I IFNs following reovirus infection of primary 219 murine fibroblasts (13) and cardiac myocytes (23) and efficient induction of apoptosis in 220 reovirus-infected cells (13). To determine the role of IRF-3 in reovirus pathogenesis, we first 221 examined whether IRF-3 influences the survival of newborn mice following inoculation with 222 reovirus strains T1L and T3SA+. T1L and T3SA+ differ in pathogenicity following infection of 223 newborn mice. T1L is a prototype strain that displays modest virulence, causing hydrocephalus 224 and mild myocarditis (16, 31, 39). T3SA+ is a reassortant virus containing nine gene segments 225 from T1L and the σ1-encoding S1 gene from strain T3C44-MA. T3SA+ is highly virulent, 226 causing lethal encephalitis and biliary injury (3, 24) . We inoculated two-day-old IRF-3 +/+ and 227 IRF-3 -/-C57Bl/6-J mice perorally with either 10 7 PFU of T1L or 10 4 PFU of T3SA+ (Fig. 1) . 228
Mice were monitored for signs of disease daily for 21 d and euthanized when moribund. 229
Following inoculation with the mildly virulent strain T1L, approximately 45% of the IRF-3-230 deficient animals succumbed to infection, whereas no IRF-3 +/+ mice developed detectable 231 clinical signs ( Fig. 1A ; P < 0.001). In contrast, the majority of IRF-3 +/+ and IRF-3 -/-mice 232 succumbed to infection with the highly virulent strain T3SA+ (Fig. 1B) . These results suggest 233 that IRF-3 attenuates the virulence of a moderately pathogenic but not a highly pathogenic 234 reovirus strain. 235
To determine whether IRF-3 influences reovirus virulence following direct inoculation 236 into a site of secondary replication, we monitored survival after IC inoculation of two-day-old 237 To test whether differences in survival following PO inoculation of T1L are attributable 242 to differences in the capacity of this strain to disseminate from the initial site of replication, we 243 quantified viral titers at sites of primary and secondary replication at various times after 244 inoculation (Fig. 2) . Reovirus T1L produced significantly higher titers in IRF-3-deficient animals 245 at the site of primary replication in the intestine in comparison to wild-type animals at all time 246 points measured. Virus titers at sites of secondary replication were 10-to 100-fold higher in IRF-247 3-deficient animals at day 2 post-inoculation, yet peak titers did not differ significantly. fibroblasts (13). We hypothesized that differences in viral titer observed at early times at the site 263 of primary replication in mice might be attributable to altered IFN-β production. To test this 264 hypothesis, we quantified IFN-β mRNA levels in the intestine on days 1 through 4 post-265 inoculation using qRT-PCR (Fig. 3) . On day 1 post-inoculation, IFN-β expression levels were 266 significantly elevated in response to T1L infection in wild-type mice, whereas expression levels 267 in IRF-3-deficient mice were similar to those in mock-infected controls. On days 2 and 3 post-268 inoculation, IFN-β transcript abundance decreased to levels just above background, although 269 levels in wild-type mice were significantly greater than those in IRF-3-null mice. By day 4, 270 significant differences in transcript abundance in the two mouse strains were not observed. showed inflammatory lesions that distribute within regions of cells that stain for reovirus antigen 287 and the activated form of caspase-3, consistent with mild myocarditis (Fig. 4B) . In contrast, 288 sections of hearts from IRF-3-deficient mice displayed large lesions with almost complete tissue 289 destruction and numerous cells that stain for reovirus and activated caspase-3. Regions that 290 contained activated caspase-3 immunoreactivity also were positive by TUNEL assay (data not 291 shown), which marks apoptotic DNA fragments, confirming that apoptosis is associated with 292 these cardiac lesions. These findings suggest that IRF-3 attenuates reovirus-induced myocarditis. 293
Damage to the heart induced by reovirus infection of IRF-3 -/-mice was independent of 294 the route of inoculation. Following IC inoculation of mice with T1L, neither wild-type nor IRF-295 3-null animals displayed signs of CNS disease, and reovirus tropism in the CNS was not altered 296 by the absence of IRF-3 (data not shown). In contrast, gross pathologic lesions were observed in 297 the hearts of IC-inoculated IRF-3-null mice (data not shown), suggesting that these animals 298 succumbed to reovirus myocarditis. 299
Inhibition of reovirus-induced cardiac pathology in wild-type animals could be caused by 300 a systemic IFN response induced at the initial site of replication or a localized response within 301 cardiac tissue. To distinguish between these possibilities, we assayed IFN-β in the serum of 302 reovirus-infected wild-type and IRF-3-null animals by ELISA. In these experiments, IFN-β was 303 not detected in the serum of either mouse strain (data not shown). Therefore, we examined the post-inoculation, spleens were resected from mock-and T1L-infected wild-type and IRF-3-317 deficient animals, and splenocytes were isolated. Splenocytes were incubated with mock-or 318 T1L-infected haplotype-matched fibroblasts in the presence of IL-2 and a protein secretion 319 inhibitor. Splenocytes were fixed and stained using fluorescently-conjugated anti-CD8 and IFN-320 γ antibodies and analyzed by flow cytometry (Fig. 6A) . No significant differences were observed 321 in the number of activated CD8 + T cells in spleens from wild-type and IRF-3-deficent mice, 322
indicating that the capacity of CD8 + T cells to mount a cytokine response to antigen was not 323 altered by the lack of IRF-3. 324
To determine whether the humoral immune response was affected by the absence of IRF-325 3, we quantified reovirus-specific serum IgG titers in wild-type and IRF-3-deficient mice at days 326 8 and 12 post-inoculation using a whole-virus ELISA (Fig. 6B) . Serum IgG levels in wild-type 327 and IRF-3-deficent mice did not differ at either of these time points. Collectively, these data 328 In this study, we found that innate immune response transcription factor IRF-3 attenuates 334 disease caused by a mildly pathogenic reovirus strain, T1L, but not a highly pathogenic strain, 335 T3SA+. Remarkably, T1L produces fulminant myocarditis in IRF-3-deficient mice regardless of 336 the inoculation route (Fig. 4 and data not shown) , indicating that IRF-3 exerts a key protective 337 effect in the heart. IRF-3 also serves a critical function in reovirus clearance, which appears to be 338 independent of IRF-3 effects on the development of an adaptive immune response. Innate immune processes can dictate organ-and cell type-specific differences in reovirus 366 disease. Cell-culture models of reovirus infection have ascribed pro-apoptotic functions to both 367 NF-κB and IRF-3 in a variety of cell types, including both immortalized cell lines and primary 368 murine embryonic fibroblasts (5, 12, 13). NF-κB also mediates a pro-apoptotic response to 369 reovirus infection in the CNS of neonatal mice (24). We did not observe differences in CNS 370 pathology in wild-type and IRF-3-deficient mice, likely because T1L is not neurotropic and does 371 not induce apoptosis in the CNS. However, in the myocardium, NF-κB protects against apoptotic 372 injury (24), and our results suggest that IRF-3 has a similar function. 373
There are three possible mechanisms that might account for the discrepancy between the 374 requirement for NF-κB and IRF-3 in apoptosis induction in cell culture versus the neonatal heart. 375 
